Analysis of:
ECTRMS: Family History Worsens MS Severity (www.medpagetoday.com)
The MS research team at UCSF is one of the most authoritative and reliable groups in the world and Dr. Zivdanov is a prominent research neurologist. This study provides valuable insights on the genetics of MS.
September 25, 2007Good or bad
Analysis of:
FDA Approves New Dosage Strength Of Stalevo (www.therapeuticsdaily.com)
It will be good in the sense it provide more choices for us It may not be so good as I am not sure whether the new doseage strength version will have a different patent period from the original ones.
Analysis of:
Actelion Sleep Aid Does Well (online.wsj.com)
The new medication works on a totally different mechanism from all other hypnotics medications. It directly targets on regulation of wakefulness. It can potentially be used as monotherapy or in combination. Orexin, the chemical released by hypothalamus neurons in the brain is also involved in weight...
Analysis of:
Painkiller Widely Abused in South (www.washingtonpost.com)
The article describes the increase in hydrocodone abuse, especially in the Southern and Rural US.
Analysis of:
American's Gamble for Bargain Surgery Abroad (www.medpagetoday.com)
The article describes several examples of medical tourism with different motivations and risks involved.
Analysis of:
Oncoscience AG, the european partner of YM BioSciences, announces completion of patient enrollment in phase III brain cancer trial of nimotuzab (www.pipelinereview.com)
The articel discusses Oncoscience AG, the european partner of YM BioSciences experimenal treatment for gliomas. It is based on a monoclonal antibody to EGFR and is being tested in combination with other treatments including radiation.
Analysis of:
New Treatment Boosts Muscle Function In Myasthenia Gravis (www.medicalnewstoday.com)
The article reports on an open label study recently published in Neurology. Apparently a new treatment (oral EN101 antisense) appears to be effective at improving muscle strength and reducing fatigue in people with MG.
Analysis of:
Genetic breakthrough offers MS sufferers hope of new treatment (www.timesonline.co.uk)
Two genes have been linked to an increased risk for the development of MS. Several researchers speculate on the ipact this may have on future treatments.
Analysis of:
Industry Fights Switch to Generics for Epilepsy (online.wsj.com)
The epilepsy foundation and major drug manufacturers have teamed up to protect reimbursments for branded anti-epilepsy drugs.
Analysis of:
Industry Fights Switch to Generics for Epilepsy (online.wsj.com)
The epilepsy foundation and major drug manufacturers have teamed up to protect reimbursments for branded anti-epilepsy drugs.